SCHEMBL6340801

SCHEMBL6340801

COC(=O)c1ccccc1NC(=O)Cc1ccc(Oc2ccc(OCc3cccc(NC(C)=O)c3)cc2)cc1

nearest known ligand 0.48

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 1/20 0.48
RAB9A P51151 1/20 0.48
ALDH1A1 P00352 1/20 0.48
TSHR P16473 1/20 0.48
MAPK10 P53779 1/20 0.48
HSD17B10 Q99714 1/20 0.48
NLRP3 Q96P20 3/20 0.47
L3MBTL1 Q9Y468 1/20 0.47
CLCN2 P51788 1/20 0.47
KMT2A Q03164 2/20 0.46
MEN1 O00255 1/20 0.46
ALOX15 P16050 1/20 0.46
HTT P42858 1/20 0.46
USP2 O75604 1/20 0.46
KDM4E B2RXH2 1/20 0.46
MAOB P27338 1/20 0.46
SIRT2 Q8IXJ6 1/20 0.46
SIRT1 Q96EB6 1/20 0.46
SIRT3 Q9NTG7 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6338576 0.90 PPARD (0.55) NPC1RAB9AALDH1A1KMT2AMEN1
SCHEMBL6340331 0.88 SIRT2 (0.51) NPC1RAB9AALDH1A1TSHRMAPK10
SCHEMBL6349020 0.87 ALDH1A1 (0.60) NPC1RAB9AALDH1A1TSHRMAPK10
SCHEMBL6344805 0.84 ALDH1A1 (0.52) RAB9AALDH1A1TSHRMAPK10HSD17B10
SCHEMBL6340720 0.82 ALDH1A1 (0.52) RAB9AALDH1A1TSHRMAPK10HSD17B10
Benzoic Acid SCHEMBL8041305 0.82 ALDH1A1 (0.55) NPC1RAB9AALDH1A1TSHRMAPK10
SCHEMBL8041179 0.81 ALDH1A1 (0.52) NPC1RAB9AALDH1A1TSHRMAPK10
SCHEMBL8037895 0.80 ALDH1A1 (0.64) RAB9AALDH1A1TSHRMAPK10HSD17B10
SCHEMBL6340707 0.80 KMT2A (0.61) ALDH1A1TSHRMAPK10HSD17B10L3MBTL1
SCHEMBL8037864 0.79 SMN1; SMN2 (0.58) ALDH1A1TSHRMAPK10HSD17B10L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6890932-B2 Immunoglobulin e antibody suppressors TEIJIN LIMITED (JP) 2005-05-10 US disclosed
EP-1101755-B1 ANTHRANILIC ACID DERIVATIVES TEIJIN LTD (JP) 2004-10-06 EP disclosed
US-20030232811-A1 Immunoglobulin e antibody suppressors TEIJIN LIMITED 2003-12-18 US disclosed
US-6649656-B1 Anticarcinogenic, antiallergen, antishock, and antiasthmatic agents TEIJIN LIMITED (JP) 2003-11-18 US disclosed
EP-1101755-A1 ANTHRANILIC ACID DERIVATIVES TEIJIN LIMITED (JP) 2001-05-23 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030232811-A1 Immunoglobulin e antibody suppressors IGLV6-57, FCGRT, IGSF11 NPC1 3225/4885RAB9A 1825/4885ALDH1A1 250/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.